SCHEMBL9449173

SCHEMBL9449173

CCc1cc(C=O)c(OCc2ccccc2)nc1COCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
TSHR P16473 3/20 0.38
ERN1 O75460 2/20 0.37
HCAR2 Q8TDS4 1/20 0.37
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CDK1 P06493 2/20 0.35
CCNB1 P14635 2/20 0.35
CCNB2 O95067 1/20 0.35
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
MGMT P16455 1/20 0.35
CCNA2 P20248 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9338308 0.83 L3MBTL1 (0.48) ALDH1A1GAAL3MBTL1MAOAMAOB
SCHEMBL9680846 0.81 L3MBTL1 (0.40) ALDH1A1L3MBTL1TSHRHCAR2NPC1
SCHEMBL9449258 0.79 CNR1 (0.47) L3MBTL1MAOBTSHRGHSR
SCHEMBL9449238 0.79 ATP4A (0.40) L3MBTL1NPC1RAB9A
SCHEMBL9449235 0.79 ATP4A (0.40) L3MBTL1NPC1RAB9A
SCHEMBL9680900 0.76 HCAR2 (0.32) HCAR2
SCHEMBL9680902 0.76 HCAR2 (0.32) HCAR2
SCHEMBL9681900 0.76 HCAR2 (0.32) ALDH1A1TSHRHCAR2SMN1; SMN2
SCHEMBL15088137 0.76 L3MBTL1 (0.46) ALDH1A1GAAL3MBTL1MAOAMAOB
SCHEMBL9681317 0.75 DAGLA (0.34) HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5202243-A Biosynthetic hydroxylation yields polymerase inhibitors MERCK & CO., INC. (US) 1993-04-13 US disclosed
US-5185251-A Treatment of HIV and AIDS MERCK & CO., INC. (US) 1993-02-09 US disclosed
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP disclosed
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed